MRI-Guided radiation trial aims to sharper target pelvic tumors

NCT ID NCT07083648

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a new method of radiation therapy, which uses an MRI scan to plan treatment and a CT scan to deliver it, is feasible for treating pelvic lymph node metastases. Twenty adults with confirmed cancer spread to pelvic lymph nodes will receive stereotactic body radiation therapy (SBRT) using this approach. The main goal is to see if the MRI-adapted plan can be successfully delivered in 90% of cases.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PELVIC AND PARA-AORTIC LYMPH NODE METASTASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Zurich University Hospital, Department of Radiation Oncology

    Zurich, Canton of Zurich, 8091, Switzerland